|
|
|
| Unlock the future of advanced therapy medicinal products and antibody-drug conjugates using advanced analytics at the 2025 ISPE Aseptic Conference, taking place March 17-18 in Washington D.C., United States and virtually. Breakout sessions and panel discussions will focus on the following tracks: Advanced Modalities, Advanced Therapy Medicinal Products (ATMPs), Case Studies, Filling Operations, Regulations and Pharma 4.0™, and Sterility and Release. Learn more and register. |
|
|
|
|
|
| Using Synthesis And Route Design Technology To Approach API Complexity | Article | By Dr. Juergen Swienty-Busch, Elsevier Information Systems and Dr. Ryan Littich, Lonza | Leveraging computer-aided synthesis design technology and route scouting in the early stages of development can aid you in designing an efficient and cost-effective path to API manufacturing. |
|
|
| Validating Pharma 4.0 For Smart Manufacturing | Article | ValGenesis | Explore the digital evolution of manufacturing control and management, the building blocks of Pharma 4.0, and how the life sciences industry can realize the full potential of Pharma 4.0. |
|
|
| Reducing Risks In Your SIP Validation Cycles | Article | Mesa Laboratories | Utilizing tape for positioning during Sterilize in Place (SIP) validation can introduce numerous issues. Review the top eight reasons why tape should be avoided during SIP validation cycles. |
|
|
| Demolishing Doubts About AI In Pharma | Article | Aizon | Learn how two recent initiatives from the FDA and PDA are paving the way for the compliant and practical implementation of AI into pharmaceutical manufacturing. |
|
|
|
| Accelerate And De-Risk Bioconjugate Drug Development | Article | By Elisabeth Engelsberger, Ph.D., and Raphael Frey, Ph.D., Lonza | With a growing interest in developing new and improved bioconjugate drugs, explore an “innovation through collaboration” approach that can facilitate access to next-generation conjugation technologies. |
|
|
|
| Nasal Inhalation Delivery – An Introduction Guide | Article | Upperton Pharma Solutions | Unlock the potential of nasal inhalation for delivering active pharmaceutical ingredients by evaluating the advantages of both liquid and dry powder formulations as companies innovate a variety of therapies. |
|
|
|
|
|
|
|
By Sabyasachi Ghosh, Future Market Insights | As consumer preferences for natural and organic products rise, pharma and nutraceutical companies are increasingly shifting to plant-based APIs. This article shares new market research, including a spotlight on cannabis-based APIs. | |
|
|
|
|
|
|
|
|
|
|
Connect With Pharmaceutical Online: |
|
|
|